Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals | Baseline 2002 |
Actual Performance | Long-Term Goal 2010 |
|
|---|---|---|---|---|
| 2004 | 2005 | |||
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44 years of age) | 197,000 | 132,000 | 176,000 | 168,000 |
| a. Prevalence of Chlamydia in high-risk women ≤ 25 years | 10.1%* | 9.7%* | 9.2%* | 8.6%* |
| b. Prevalence of Chlamydia in women ≤ 25 years in family planning clinics | 5.6%* | 6.3%* | 6.3%* | 4.9%* |
| c. Incidence of Gonorrhea/100,000 population in women 15-44 years of age | 279 | 267 | 276 | 237 |
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) | 2.4 | 2.7 | 3.0 | 2.2 |
| a. Incidence of P&S Syphilis/100,000 population - men | 3.8 | 4.7 | 5.1 | 4.2 |
| b. Incidence of P&S Syphilis/100,000 population - women | 1.1 | 0.8 | 0.9 | 0.38 |
| c. Incidence of Congenital Syphilis/100,000 live births | 10.2 | 9.1 | 8.0 | 3.9 |
| d. Black:white rate ratio of P&S Syphilis | 8:1 | 5.5:1 | 5.4:1 | 3:1 |
| GPRA Goals | Data Source |
|---|---|
| 1 | National Disease and Therapeutic Index (IMS Health). |
| 1a | National Job Training Program. |
| 1b | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 1c | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2 | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2a | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2b | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2c | STD Surveillance System (STDSS), CDC, NCHSTP. |
| 2d | STD Surveillance System (STDSS), CDC, NCHSTP. |
*Median state-specific chlamydia prevalence among women was not adjusted for
changes in laboratory test method and associated increases in test sensitivity.
